ClinicalTrials.govrestricted
The Effects of Omalizumab (Anti-IgE) on the Late-phase Response to Nasal Allergen Challenge
ClinicalTrials.gov study NCT01003301. IPD Sharing: Not stated. Countries: 1. Publications: 30.
ShareScore
36/100
Overall dataset sharing score
Score breakdown
These five areas show where the dataset supports — or may limit — practical reuse.
- Stewardship
- 12
- Harmonization
- 12
- Access
- 4
- Reuse readiness
- 0
- Engagement
- 8
Topics
ScienceDex for faculty
Your academic CV and NIH biosketch
Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.